China Sets The Stage For Its Innovation Entrance
Executive Summary
China is coming up fast on the innovation curve as a result of political will and a healthy ecosystem that supports R&D. It will take time to challenge the major players from the US and Europe, but there are few that doubt China can, eventually, do so.
You may also be interested in...
Wuxi Pushing Ahead with $3bn Go-Private Deal
Despite the market turmoil on China’s stock exchanges since June, US-listed Chinese healthcare-related companies have not stepped back from privatization plans and the consideration of floating again on Chinese bourses, given the encouraging policies and promising development environment in the country.
Merck dissolves Simcere JV amid rapid China changes
Once hailed as the model for global going local in China, a joint venture created merely three years ago between Merck and Simcere has quietly faded into history. Does the move signal that the JV model is not working in China?
AstraZeneca takes Nobel alliance to China to spread innovation message
AstraZeneca has expanded its tie-up with the Nobel Foundation to include China, rolling out the AstraZeneca Nobel Medicine Initiative in Shanghai in a bid to encourage innovation in a market not traditionally known for it.